Switzerland is paving the way for a groundbreaking reform in cannabis policy. After successful pilot projects, the nation is moving towards full legalisation, focusing on public health and reducing the illicit market. eu1.hubs.ly/H0m3NyR0

SOMAÍ, a leading EU-GMP-certified Multi-Country Operator, continues its global expansion—this time entering the Italian market through a strategic partnership with Materia Medica Processing, Italy’s premier pharmaceutical cannabis distributor. eu1.hubs.ly/H0m3NW50

Die Schweiz ebnet den Weg für eine wegweisende Reform der Cannabispolitik. Nach erfolgreichen Pilotprojekten plant das Land die vollständige Legalisierung – mit Fokus auf Gesundheitsschutz und der Eindämmung des Schwarzmarkts. eu1.hubs.ly/H0m3NwV0

As the UK’s medical cannabis patient population surpasses 60,000, we spoke to Curaleaf UK MD Jonathan Hodgson about what’s next: from growing patient demand and evolving product formats to manufacturing strategy and regulatory reform. Read here: eu1.hubs.ly/H0m6qKk0

Slovenia takes a step toward cannabis reform. A draft bill from Slovenia’s ruling coalition would legalise limited personal use and home cultivation of cannabis following a slim public mandate and growing European momentum for reform. eu1.hubs.ly/H0m6qqS0

Limited prescriber availability and mounting demand are creating new ethical challenges in the UK's #medicalcannabis sector, especially around consultation lengths. Releaf argues that scale and safety need not be mutually exclusive. eu1.hubs.ly/H0m7VzK0

France’s medical cannabis programme, once on the brink of collapse, is now advancing—after years of delays, the government submitted its full proposal to the EU in March 2025. Is France set to lead the way in EU cannabis regulation? eu1.hubs.ly/H0m9MPb0

While cannabis news quiets, pharmaceutical cannabis stands out—driven by clinical advances and increased regulatory focus. Beyond the Ticker spotlights key players reshaping this competitive landscape. Read here: eu1.hubs.ly/H0mcjdW0

Despite partial legalisation, Germany has seen a 50% rise in cannabis smuggling, with over 12.6 tonnes seized in the past year. Limited access through social clubs and slow regulatory rollout are driving continued reliance on the illicit market. eu1.hubs.ly/H0md4Ph0

Trotz teilweiser Legalisierung hat der Cannabisschmuggel in Deutschland um 50 Prozent zugenommen. Im vergangenen Jahr wurden über 12,6 Tonnen beschlagnahmt. Mangelnder Zugang und langsame Umsetzung befeuern den illegalen Markt weiterhin. eu1.hubs.ly/H0md6p80

Glass Pharms has announced a new supply deal, introducing a new line of affordable, entirely UK-produced products. 3 new additions to the ‘EcoCann Access’ range, derived from Glass Pharms® sustainably grown flower, will now be prescribed via CB1 Medical. eu1.hubs.ly/H0mdG1W0

Germany’s medical cannabis imports hit a record 43.3 tonnes in Q2 2025, but looming telehealth restrictions could trigger oversupply and push patients back to the illicit market, industry groups warn. Read here for the full story: eu1.hubs.ly/H0mfwXx0

As Q2 2025 figures roll in, the gulf between the UK and German cannabis sectors is becoming clearer. While Germany’s biggest players ride a wave of medical market growth, UK firms face delistings, pivots and capital droughts. Read the full article here: eu1.hubs.ly/H0mhWHK0

In Germany, the partial legalisation of cannabis has opened up a new telemedicine market. Instead of visiting a doctor in person, patients can now request prescriptions online, with cannabis flowers sent directly to patients via specialist pharmacies. eu1.hubs.ly/H0mkvQY0

In Deutschland hat sich nach der Teillegalisierung von Cannabis ein neuer Markt in der Telemedizin eröffnet. Anstatt zum Arzt gehen zu müssen, wird online ein Rezept angefordert und Cannabis in Blütenform über spezielle Apotheken versendet. eu1.hubs.ly/H0mkwMK0

From Swissmedic licence to global GMP exports, Linnea is setting new standards for cannabis APIs. A key Prohibition Partners Insights Hub contributor, it’s shaping EU standards and building a new facility for medical cannabis derivatives. Read below. eu1.hubs.ly/H0mmSCv0

Greece’s med cannabis market opened in 2024 and is set to hit €13m in 2025 (Prohibition Partners Insights Hub). EU-GMP certified Grecan is going ‘Europe first’, signing German deals and aiming to be the first Greek exporter to the UK by Sept. eu1.hubs.ly/H0mnGyZ0

While tackling the recent torrent of illegal cannabis entering the UK is a priority, far less focus has been given to ensuring patients with legally prescribed medical cannabis are treated fairly at borders and by police. eu1.hubs.ly/H0mpTK60 @Releaf #medicalcannabis